fura-2 has been researched along with Neuroendocrine Tumors in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drost, A; Langrehr, J; Mergler, S; Neuhaus, P; Ploeckinger, U; Prada, J; Strauss, O; Strowski, M; Wiedenmann, B | 1 |
1 other study(ies) available for fura-2 and Neuroendocrine Tumors
| Article | Year |
|---|---|
Insulin-like growth factor-1 increases intracellular calcium concentration in human primary neuroendocrine pancreatic tumor cells and a pancreatic neuroendocrine tumor cell line (BON-1) via R-type Ca2+ channels and regulates chromogranin a secretion in BO
Topics: Biomarkers, Tumor; Calcium; Calcium Channels, R-Type; Cell Line, Tumor; Chromogranin A; Chromogranins; Culture Media; Electrophysiology; Fluorescent Antibody Technique; Fluorescent Dyes; Fura-2; Humans; Insulin-Like Growth Factor I; Neuroendocrine Tumors; Oligonucleotides, Antisense; Pancreatic Neoplasms; Patch-Clamp Techniques; Phenotype | 2005 |